Introduction {#s01}
============

Lethal giant larvae (Lgl) was one of the first genetically identified tumor suppressors in *Drosophila melanogaster*, as tissues in *lgl* mutant larvae show neoplastic transformation with overproliferative and metastatic phenotypes. Lgl was later also identified as a key regulator of cell polarity and asymmetric cell divisions ([@bib43]; [@bib18]). Lgl is well conserved structurally and functionally between *Drosophila* and vertebrates ([@bib18]). Although the molecular mechanisms underlying the biological activity of Lgl remain to be fully characterized, plasma membrane (PM) or cortical localization of Lgl appears to be essential. First, a temperature-sensitive Lgl (Lgl^ts^) becomes cytosolic at the restrictive temperature ([@bib34]). Second, loss of PM targeting of hLgl has been seen in multiple human cancer cells ([@bib41]; [@bib33]). Finally, phosphorylation by atypical PKC (aPKC) inhibits Lgl membrane targeting and is crucial for regulating Lgl functions in cell polarization, asymmetric cell division, and cell migration ([@bib4], [@bib5]; [@bib36]). However, molecular mechanisms mediating the PM targeting of Lgl remain to be elucidated. It has been proposed that unphosphorylated Lgl is in an open and active conformation capable of binding cortical actin network to target Lgl to PM, whereas phosphorylation on the conserved serine residues by aPKC induces a self-folded and inactive conformation that disassociates Lgl from PM ([@bib5]). Nonetheless, direct genetic and biochemical evidence supporting this model have not been demonstrated to date.

We recently generated a functional *lgl::GFP* knock-in allele in *Drosophila* using an established genomic engineering approach ([@bib24]). Live imaging experiments with Lgl::GFP revealed unexpectedly that hypoxia acutely and reversibly inhibits the PM targeting of Lgl in epithelial cells. Loss of Lgl PM targeting under hypoxia is controlled by a posttranslational mechanism that is independent of phosphorylation or the cortical actin network. Led by such observations, we identified that in both *Drosophila* and mammalian cells, the PM targeting of Lgl is mediated by electrostatic interactions between a positively charged polybasic (PB) domain in Lgl and the negatively charged inositol phospholipids in the PM. Such PB domain--mediated PM binding provides a direct and efficient molecular mechanism for regulating Lgl PM targeting and function by phosphorylations, which neutralize the positive charges of PB domain, and by hypoxia and intracellular ATP depletion, which reduce the levels of PM inositol phospholipids.

Results {#s02}
=======

Acute and reversible regulation of Lgl PM targeting by hypoxia in *Drosophila* epithelial cells {#s03}
-----------------------------------------------------------------------------------------------

Homozygous *lgl::GFP* knock-in flies are viable, healthy, and fertile, indicating that the Lgl::GFP fusion protein expressed under its endogenous promoter fully substitutes the wild-type Lgl throughout development ([@bib24]). Under normal conditions, Lgl::GFP in embryonic epithelia predominantly localizes to basolateral PM/cell cortex ([Fig. 1 A](#fig1){ref-type="fig"}). However, we fortuitously discovered that Lgl::GFP in embryos became cytosolic under hypoxic conditions. Using an environmentally controlled micro-imaging chamber, we confirmed that under hypoxic (0.5 or 1% O~2~) conditions, Lgl::GFP completely diffused from PM to the cytosol within 30--60 min ([Fig. 1 A](#fig1){ref-type="fig"}). Surprisingly, once normoxia was resumed, Lgl::GFP rapidly and completely relocalized back to PM within minutes ([Fig. 1 A](#fig1){ref-type="fig"}). Lgl diffusion under hypoxia is also seen in larval, pupal, and adult epithelial tissues, and we developed protocols for robust ex vivo hypoxia assays in follicular epithelia from dissected adult female ovaries ([Fig. 1 B](#fig1){ref-type="fig"} and [Videos 1](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp1} and [2](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp2}). We confirmed that loss of Lgl PM targeting is not caused by disruption of cell polarity or the cortical actin network under hypoxia, as subcellular localization of several key cell polarity proteins including DE-Cad::GFP ([@bib24]), β-catenin::GFP ([@bib15]; [@bib26]), Bazooka(dPar-3)::GFP, and Dlg::GFP ([@bib30]; [@bib9]) remain unchanged under hypoxia ([Fig. S1, A--C](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp3}). MoeAD::GFP ([@bib7]) and Sqh::GFP ([@bib40]), two well-established markers for the actomyosin network, also remain unchanged under hypoxia ([Fig. 1 C](#fig1){ref-type="fig"}). Loss of PM-localized Lgl under hypoxia is not caused by the fusion of GFP moiety either, as endogenous Lgl showed similar diffusion from PM under hypoxia ([Fig. 1 D](#fig1){ref-type="fig"}). Our data revealed for the first time that hypoxia acutely and reversibly inhibits the potential PM targeting of Lgl protein in vivo.

![**Acute and reversible subcellular relocalization of Lgl::GFP under hypoxia.** (A) Lgl::GFP localization in late embryonic epithelial cells under normoxia (i.e., 21% O~2~), 60 min of 0.5% O~2~ hypoxia, and 10 min of post-hypoxia reoxygenation with air. (B) Lgl::GFP subcellular localization in adult female ovary follicular cells under normoxia, 35 min of 0.5% O~2~ hypoxia, and 2 min of post-hypoxia reoxygenation with air. Histone::RFP (i.e., His2Av::RFP; red) indicates nuclear DNA. (C) Actin cytoskeleton (labeled by MoeAD::GFP) and cortical myosin network (labeled by Sqh::GFP) do not show obvious disruptions under hypoxia. In hypoxia imaging assays, *MoeAD::GFP* or *sqh::GFP* embryos were mixed with *lgl::GFP his2Av::RFP* embryos, which were used to confirm the effective hypoxic exposures (*n* = 8). (D) Hypoxia-treated *lgl::GFP* or wild-type embryos were immunostained by anti-GFP or anti-Lgl antibody together with anti-Baz antibody, with normoxia-treated embryos as controls (*n* = 8). (E) A representative FRAP sample of Lgl::GFP in late-stage (stage 15) embryo going through hypoxia and reoxygenation. Image is in inverted grayscale for better presentation. (F) FRAP results of Lgl::GFP in embryos treated with hypoxia/reoxygenation (*n* = 6) and in embryos staying in normoxia (*n* = 8). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. *ns*, not significant. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig1){#fig1}

Hypoxia inhibits Lgl PM targeting via a posttranslational mechanism that is modulated by HIF pathway but is independent of phosphorylations {#s04}
-------------------------------------------------------------------------------------------------------------------------------------------

Hypoxia regulates the nuclear relocalization of hypoxia-inducible factor 1α (HIF1α) through inhibiting its protein degradation induced by prolyl hydroxylase domain (PHD) proteins ([@bib28]). To investigate whether loss of Lgl PM targeting under hypoxia also involves Lgl protein degradation and synthesis, we performed whole-cell FRAP assays ([@bib26]) by photobleaching the Lgl::GFP in a patch of epithelium so that Lgl::GFP can only be recovered through de novo protein synthesis. As shown in [Fig. 1 (E and F)](#fig1){ref-type="fig"}, unlike unbleached cells, photobleached cells never recovered their Lgl::GFP under hypoxia and subsequent reoxygenation. Whole-cell FRAP assays in fact revealed that Lgl::GFP has an extremely slow turnover rate even under normoxia ([Fig. 1 F](#fig1){ref-type="fig"}). Thus, loss of PM-targeted Lgl::GFP under hypoxia involves no detectable Lgl::GFP synthesis and degradation, suggesting that hypoxia directly inhibits the PM targeting of Lgl. We then tested whether on the other hand HIF1α is required for inhibiting the PM targeting of Lgl::GFP using *Drosophila HIF1*α (namely, *sima* or *dHIF*α) or *PHD* (*fatiga* or *hph*) mutants ([@bib32]; [@bib12]). Inhibition of PM Lgl::GFP by hypoxia is unchanged in *sima* or *fatiga sima* double mutant embryos ([Fig. 2 A](#fig2){ref-type="fig"}) but is delayed in Sima-overexpressing follicular cells ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp4}) or in *fatiga* mutants that have high Sima levels as a result of loss of Fatiga ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib32]). Our data suggest that high levels of Sima proteins promote rather than inhibit the PM targeting of Lgl under hypoxia (see below).

![**Inhibition of Lgl PM targeting by hypoxia is modulated by HIF pathway but is independent of phosphorylation events.** (A) Lgl::GFP showed normal subcellular relocalization in *sima* mutant embryos under hypoxia and reoxygenation (air). In *fatiga* mutant embryos, Lgl::GFP showed no significant diffusion at 60 min of hypoxia treatment, and only become diffused at 120 min of hypoxia. Lgl::GFP showed complete diffusion in *fatiga sima* double mutant embryos at 60 min of hypoxia and recovered normally during reoxygenation (*n* = 6). (B) Lgl::GFP show normal subcellular redistribution under hypoxia in either *par-6* or *aPKC* mutant follicular epithelial cell clones (*n* = 4). Mutant cells of *par-6* are marked by the absence of nuclear GFP, whereas *aPKC* mutant cells are marked by the absence of nuclear His2Av::RFP. (C) PM targeting of Lgl^S5A^::GFP is acutely and reversibly inhibited under hypoxia in follicular epithelial cells. Loss of RFP marks *lg^S5A^::GFP* clones, whereas wild-type *lgl::GFP* twin clones are labeled by increased expression of RFP (indicated by white asterisks). \*\*, P \< 0.01; \*\*\*, P \< 0.001. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig2){#fig2}

Surprisingly, hypoxia readily inhibits Lgl::GFP PM targeting in either *par-6* or *aPKC* mutant follicular cell clones ([Fig. 2 B](#fig2){ref-type="fig"} and Fig. S2 B). We also generated a *lgl^S5A^::GFP* knock-in allele in which all five conserved serines phosphorylatable by aPKC or Aurora kinases (see [Fig. 5 A](#fig5){ref-type="fig"}; [@bib3]; [@bib10]) have been mutated to alanines. PM localization of Lgl^S5A^::GFP showed acute and reversible inhibition by hypoxia identical to Lgl::GFP ([Fig. 2 C](#fig2){ref-type="fig"}). In addition, although aPKC also shows loss of PM localization under hypoxia (Fig. S2 C), overexpression of membrane-bound aPKC^CAAX^ ([@bib42]) did not rescue the loss of Lgl PM targeting under hypoxia (Fig. S2 D). Thus, we conclude that hypoxia directly inhibits Lgl PM targeting through a posttranslational mechanism that is modulated by Sima protein levels but is independent of phosphorylation events by aPKC/Aurora kinases or physical interactions between Lgl and aPKC.

Reduction of intracellular ATP is sufficient to inhibit PM targeting of Lgl in both *Drosophila* and mammalian cells {#s05}
--------------------------------------------------------------------------------------------------------------------

Hypoxia acutely and reversibly inhibits ATP production in *Drosophila* embryos, and the time course of intracellular ATP level reduction and recovery ([@bib17]) is very similar to that of Lgl::GFP ([Fig. 1 F](#fig1){ref-type="fig"}). Indeed, both Lgl::GFP and endogenous Lgl diffused from PM to cytosol in embryos and female ovaries treated with cyanide and antimycin A (AM), which inhibit ATP production ([Fig. 3, A and B](#fig3){ref-type="fig"}; and [Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp5}; [@bib17]), and we confirmed that hypoxia and cyanide treatments all reduced intracellular ATP levels in embryos (Fig. S3 B). Thus, reduction of intracellular ATP levels appears to mediate the hypoxia-induced inhibition of Lgl PM targeting. In addition, live imaging using a custom micro-imaging chamber showed that mouse Lgl::GFP (mLgl::GFP) localized strongly to the PM under normoxia in both HEK293 and Madin-Darby canine kidney (MDCK) cells, diffused into cytosol after one to several hours of hypoxic exposure and quickly retargeted to PM within 30 min of reoxygenation ([Fig. 3 C](#fig3){ref-type="fig"} and [Videos 3](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp6} and [4](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp7}). Blocking ATP production in HEK293 cells by 2-deoxyglucose (2-DG) and AM caused loss of mLgl::RFP PM targeting that was reversed by drug removal, whereas a palmitoylation-based membrane marker GAP43::GFP ([@bib35]) remained on the PM ([Fig. 3 D](#fig3){ref-type="fig"}). Finally, endogenous hLgl-2 was also lost from PM in hypoxia-treated MCF-7 cells (Fig. S3 C). Thus, acute and reversible inhibition of Lgl PM targeting by hypoxia and intracellular ATP reduction is conserved in both *Drosophila* and mammalian cells. We speculate that high Sima protein levels likely have made ATP production in *fatiga(dPHD)* mutant embryos or Sima-overexpression follicular cells more resistant to hypoxia ([@bib1]), resulting in delayed loss of Lgl::GFP from PM.

![**Hypoxia and reduction of intracellular ATP levels inhibit the PM targeting of Lgl in both *Drosophila* and mammalian cells.** (A) *lgl::GFP* embryos were treated with PBS (control) or 0.5% cyanide (CN). Embryos were double labeled by anti-Baz (red) and anti-GFP or anti-HA (green) antibodies (*n* = 6). (B) Dissected ovaries from *lgl::GFP* females that were treated with 1 µM AM or 0.5% cyanide (*n* = 6). PBS and 1% DMSO served as controls. (C) Inhibition of mLgl::GFP PM targeting in hypoxia-treated MDCK or HEK293 cells (*n* = 4). (D) Inhibition of ATP production by 2-DG and AM in HEK293 cells induced loss of mLgl::RFP from PM that can be reversed when drugs were washed out. PM localization of GAP::GFP is unaffected (*n* = 4). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. *ns*, not significant. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig3){#fig3}

An evolutionarily conserved PB domain is essential for Lgl PM targeting {#s06}
-----------------------------------------------------------------------

Given that hypoxia inhibits Lgl PM targeting without disrupting the cortical actin network ([Fig. 1 C](#fig1){ref-type="fig"}), we decided to determine whether the cortical actin network is indeed required for Lgl PM targeting as reported previously ([@bib5]). We repeated the latrunculin treatment used by [@bib5] to disrupt F-actin in *Drosophila* embryos. Despite severe disruption of cortical F-actin indicated by the loss of MoeAD::GFP ([Fig. 4 A](#fig4){ref-type="fig"}) or phalloidin staining (Fig. S3 D), Lgl (shown by immunostaining; Fig. S3 D), Lgl::GFP (Fig. S3 D), and Lgl::mCherry (shown by live imaging; [Fig. 4 A](#fig4){ref-type="fig"}) remain localized on the PM in treated embryos. We also depolymerized F-actin in MDCK cells by cytochalasin D, and mLgl::GFP still remained on PM ([Fig. 4 B](#fig4){ref-type="fig"}). Our data strongly suggest that PM targeting of Lgl does not depend on an intact cortical actin network.

![**Lgl membrane targeting does not require intact actin cytoskeleton.** (A) *Drosophila* embryos of *lgl::RFP MoeAD::GFP* were treated with 10 µM latrunculin-A (LAT) with 0.5% ethanol (EtOH) as control. Each pair of control and treated samples was captured under identical imaging parameters and processed identically. Actin was visualized by MoeAD::GFP (*n* = 4). (B) MDCK cells were treated with 25 µg/ml cytochalasin D (CytoD), with 0.5% ethanol as control. Actin was visualized by TRITC-phalloidin staining (*n* = 4). Each pair of control and treated samples was captured under identical imaging parameters and processed identically. \*\*, P \< 0.01; \*\*\*, P \< 0.001. *ns*, not significant. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig4){#fig4}

What is the cortical actin--independent mechanism that targets Lgl to the PM? We noticed that the sequence containing the conserved aPKC-phosphorylatable serines is in fact a typical PB domain in which half of the amino acids are either Arg or Lys residues ([Fig. 5 A](#fig5){ref-type="fig"}). It has been well demonstrated that PB domains can mediate PM-specific targeting through electrostatic interactions between their positively charged Arg or Lys residues and the negatively charged phosphatidylinositol phosphates (PIPs) such as phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 4,5-bisphosphate (PIP2), which are uniquely enriched in PM ([@bib23]; [@bib44]; [@bib20]). The PB domain in Lgl is absent in the yeast Lgl homologue Sro7 but is highly conserved between mammalian and *Drosophila* Lgl proteins ([Fig. 5 A](#fig5){ref-type="fig"}). In addition, according to [@bib22], both Sro7 and Lgl proteins form two β propellers that each contains seven WD40 repeats, and the PB domain in Lgl was predicted as part of a loop between the 10th and 11th WD40 blades of the second β propeller. The Sro7 structure also suggests that the Lgl loop is likely accessible for binding PM or proteins like aPKC ([Fig. 5 A](#fig5){ref-type="fig"}). Moreover, PB domain in Lgl contains hydrophobic residues such as leucine and phenylalanine ([Fig. 5 A](#fig5){ref-type="fig"}), a key feature that has been shown to enhance PB domain's binding to PM and to prevent the PB domain from acting as a nuclear localization signal ([@bib23]).

![**An evolutionarily conserved PB domain in Lgl mediates its PM targeting.** (A) Lgl contains a conserved PB domain. (Bottom) Surface and cartoon models of Sro7 structure (Protein Data Bank accession no. [2OAJ](2OAJ); [@bib22]) rendered by PyMOL software. β sheets are in green to highlight the WD40 blades, of which each contains four β sheets. The "loop" in between WD40 blade 10 and 11 is in magenta. (Top) Alignment of the loop regions between 10D and 11A β sheets in Lgl or Sro7. Positively charged Lys and Arg residues within the loop sequences are in red, and PB domains are boxed. Blue arrowheads point to the conserved Ser residues (in blue) that can be phosphorylated by aPKC (Ser residues in green numbers are also Aurora kinase phosphorylation sites). Ser residues were numbered based on *Drosophila* Lgl (dLgl) isoform A (gi24464586). hLgl1/2, human Lgl1/2 (gi 62912476 and 40674459); mLgl1/2, mouse Lgl1/2 (gi 56800067 and 21703874); S_Sro7, *Saccharomyces cerevisiae* Sro7 (gi 6325289). Sequence alignments are modified from [@bib22]. Complete sequence alignments can be found in Fig. S2 by [@bib22]. (B) Subcellular localization of mLgl::GFP (WT), mLgl^ΔPB^::GFP (ΔPB), mLgl^K6A^::GFP (K6A; all six lysines mutated to alanine), and mLgl^KR13A^::GFP (KR13A; all 13 lysines and arginines mutated to alanine) in HEK293 cells (*n* = 6). (C) GFP fused with wild-type loop of mLgl (Loop^WT^::GFP), but not loops carrying K6A or KR13A mutations (Loop^K6A^::GFP and Loop^KR13A^::GFP, respectively), targets to the PM in HEK293 cells. Loop^WT^::GFP is also nuclear (*n* = 6 for each sample). \*\*, P \< 0.01; \*\*\*, P \< 0.001. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig5){#fig5}

Consistently, we found that the mLgl^ΔPB^::GFP mutant that deletes the PB domain is completely cytosolic in HEK293 and MDCK cells ([Fig. 5 B](#fig5){ref-type="fig"} and [Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp8}). We then generated mLgl^K6A^::GFP and mLgl^KR13A^::GFP by replacing either all the Lys or all the Lys plus Arg residues in the PB domain with alanines, respectively. mLgl^K6A^::GFP showed dramatically reduced PM targeting, whereas mLgl^KR13A^::GFP is completely cytosolic ([Fig. 5 B](#fig5){ref-type="fig"} and Fig. S4 A). GFP fused with the wild-type loop of mLgl, but not loops carrying K6A or KR13A mutations, also showed PM targeting in HEK293 cells ([Fig. 5 C](#fig5){ref-type="fig"}). To confirm that this PB domain--targeting mechanism is also conserved in *Drosophila*, we made similar knock-in mutants *lgl^ΔPB^::GFP* and *lgl^KR12A^::GFP* and, as expected, both mutant proteins showed drastically reduced PM targeting in mutant follicular cell clones ([Fig. 6 A](#fig6){ref-type="fig"}). The residual PM localization of Lgl^ΔPB^::GFP or Lgl^KR12A^::GFP is sensitive to hypoxia ([Fig. 6 B](#fig6){ref-type="fig"}), suggesting an additional electrostatic interaction--based targeting mechanism likely acting in partial redundancy to the main PB domain in Lgl. Nonetheless, both *lgl^KR12A^::GFP* and *lgl^ΔPB^::GFP* are homozygous lethal with *lgl* phenotype, and their follicular cell mutant clones show overproliferation and loss of polarity phenotypes ([Fig. 6 C](#fig6){ref-type="fig"} and Fig. S4 C) similar to *lgl^null^* clones. Previous studies suggest that Lgl may function as an inhibitive substrate of aPKC ([@bib39]; [@bib43]; [@bib19]); therefore, phenotypes by *lgl^ΔPB^::GFP* and *lgl^KR12A^::GFP* could be caused by elevated aPKC activity, as Lgl^KR12A^ and Lgl^ΔPB^ are unlikely able to bind and inhibit aPKC. Nonetheless, phenotypes in *lgl^KR12A^*mutant cells are not rescued by knocking down aPKC (Fig. S4 D). Collectively, our data indicate that PB domain--mediated PM targeting is specifically required for Lgl functions in vivo.

![**Lgl PB domain is essential for its PM targeting and functions in *Drosophila*.** (A) Subcellular localization of Lgl^ΔPB^::GFP (ΔPB) and Lgl^KR12A^::GFP (KR12A; all lysines and arginines mutated to alanine) in *Drosophila* follicular cells (*n* = 8 each). Cells homozygous of *lgl^ΔPB^::GFP* or *lgl^KR12A^::GFP* were labeled by the loss of RFP. (B) Residual PM targeting of Lgl^KR12A^::GFP is also reversibly inhibited under hypoxia in follicular epithelial cells. Loss of RFP marks *lgl^KR12A^::GFP* clones, whereas wild-type *lgl::GFP* twin clones are labeled by increased expression of RFP (indicated by white asterisks). (C) Follicular cell clones of Lgl^ΔPB^::GFP (ΔPB) or Lgl^KR12A^::GFP (KR12A) show overproliferation and loss of polarity. Polarity protein dPatj (red) localizes to the apical side in wild-type follicular cells but is mislocalized in *lgl^ΔPB^::GFP* or *lgl^KR12A^::GFP* mutant cells (labeled by the loss of GFP; blue), which also become multilayered. White boxes in the right of most panels highlight the area enlarged in the left panels. \*\*\*, P \< 0.001. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig6){#fig6}

Targeting of Lgl requires PIPs on PM {#s07}
------------------------------------

We then investigated whether PIPs that are uniquely enriched on PM such as PI4P and PIP2 are required for targeting Lgl to PM. We first treated cells with ionomycin and phenylarsine oxide (PAO), which have been well characterized for inhibiting the electrostatic binding of polycationic proteins to PM by disrupting the PM phospholipids ([@bib44]; [@bib20]). Both treatments diffused PM-localized mLgl::RFP in HEK293 cells and Lgl::GFP in *Drosophila* follicular cells, as well as PLCδ-PH::GFP marker, which specifically binds to PIP2 ([Fig. S5, A and B](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp9}). Second, we used an inducible heterodimerization system in which the addition of rapamycin recruits to the PM a hybrid phosphatase Pseudojanin (PJ) that acutely depletes both PIP2 and PI4P ([@bib20]). As shown in [Fig. 7 A](#fig7){ref-type="fig"}, rapamycin-triggered PM recruitment of PJ, but not enzymatically dead PJ, acutely and completely diffuses mLgl::GFP from PM in HEK293 cells ([Video 5](http://www.jcb.org/cgi/content/full/jcb.201503067/DC1){#supp10}). Depleting PIP2 alone by 5-phosphatases (INPP5E) also significantly diffuses mLgl::GFP from PM, but this is substantially less complete than when combined with PI4P depletion, despite complete PIP2 elimination as indicated by the dissociation of a coexpressed iRFP::PLCδ-PH. Depleting PI4P alone by PJ-Sac phosphatase shows complete dissociation of a specific PI4P biosensor, iRFP::SidM-P4M ([@bib21]), yet a barely detectable reduction of PM mLgl::GFP ([Fig. 4 A](#fig4){ref-type="fig"}). We also performed similar dimerization assays ex vivo in *Drosophila* follicular cells coexpressing PM-bound anchor protein Lck-FRB::CFP and cytosolic mRFP::FKBP-5Ptase (i.e., INPP5E; [@bib38]). The addition of rapamycin to the medium also triggered PM recruitment of 5Ptase and concomitant reduction of Lgl::GFP from PM in follicular cells in dissected *Drosophila* ovaries ([Fig. 7 B](#fig7){ref-type="fig"}). Finally, we performed co-sedimentation assays using PIP2- and PI4P-containing liposomes and purified GST fusion proteins with mLgl loop containing either wild-type PB domain or PB domains carrying K6A or KR13A mutations. Wild-type PB domain is capable of binding both liposomes, whereas K6A or KR12A mutants are not ([Fig. 7 C](#fig7){ref-type="fig"}). In summary, our data indicate that PM targeting of Lgl is mediated by direct binding between its PB domain and inositol phospholipids PIP2 and PI4P, which are uniquely enriched at the PM. Our data also suggest that, although PIP2 appears to be the primary lipid for targeting Lgl to PM, depletion of PI4P is required for complete inhibition of Lgl PM targeting.

![**PM targeting of Lgl requires inositol phospholipids on the PM.** (A) HEK293 cells expressing mLgl::GFP or Lyn11-FRB::CFP and RFP::FKBP12-PJ (PJ) to degrade PI4P and PIP2, RFP::FKBP12-PJ-Sac (PJ-Sac) to degrade PI4P, mRFP::FKBP12-INPP5E (INPP5E) to degrade PIP2, or FKBP12-PJ-dead::RFP (PJ-dead) as a control. The addition of rapamycin induced membrane recruitment of the FKBP12-tagged enzymes. Only combined depletion of PIP2 and PI4P causes complete diffusion of mLgl::GFP, whereas complete dissociation of iRFP::PLCδ~-~PH and iRFP::SidM-P4M indicated complete depletion of PIP2 or PI4P by INPP5E and PJ-Sac, respectively. Graphs are means ± SEM of 11 ≤ *n* ≤ 19 cells from three independent experiments. (B) In *Drosophila* follicular cells expressing nuclear RFP, mRFP::FKBP-5Ptase (5Ptase) and Lck-FRB::CFP (not depicted), rapamycin addition induced PM recruitment of 5Ptase and dislocalization of Lgl::GFP from PM. Images were captured at 40 min after rapamycin or DMSO addition (*n* = 4 for each sample). (C) Liposome pull-down assays of GST and GST fusions of Lgl loop (Loop^WT^), Loop^K6A^, or Loop^K12A^. \*\*, P \< 0.01; \*\*\*, P \< 0.001. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig7){#fig7}

Hypoxia and reduction of intracellular ATP also inhibit the PM targeting of phospholipid-binding proteins {#s08}
---------------------------------------------------------------------------------------------------------

PIP2 levels on PM acutely depend on intracellular ATP levels ([@bib37]), suggesting that hypoxia inhibits Lgl PM targeting by reducing phospholipid levels on the PM through ATP depletion. Thus, hypoxia or inhibition of ATP production should also disrupt the PM targeting of other proteins that require electrostatic binding to PM inositol phospholipids. Indeed, PIP2 and PIP3 markers PLCδ-PH::GFP and GRP1-PH::GFP (i.e., tGPH; [@bib8]) showed acute and reversible loss of PM targeting under hypoxia ([Fig. 8 A](#fig8){ref-type="fig"}) in *Drosophila* follicular cells. Inhibiting ATP production in HEK293 cells also dislocalizes PLCδ-PH::GFP from PM ([Fig. 8 B](#fig8){ref-type="fig"}). Numb, a key protein regulated by asymmetric cell division, also contains a basic domain that has been shown to bind PIP2 in vitro ([@bib16]), and *Drosophila* Numb::GFP showed acute and reversible loss of PM targeting under hypoxia ([Fig. 8 A](#fig8){ref-type="fig"}) similar to Lgl::GFP. In addition, our result that PM localization of aPKC is also sensitive to hypoxia (Fig. S2 C) is consistent with observations that aPKC becomes dislocalized in PIP2-deficient cells ([@bib14]). Thus, hypoxia or reduction of intracellular ATP levels can generally inhibit the PM targeting of proteins that require binding to PM inositol phospholipids.

![**Hypoxia and reduction of intracellular ATP levels acutely deplete inositol phospholipids on PM.** (A) Hypoxia reversibly inhibits PM targeting of PLCδ-PH::GFP, GRP1-PH::GFP, and Numb::GFP in *Drosophila* follicular cells (*n* = 4). (B) Inhibition of ATP production by 2-DG and AM in HEK293 cells induced loss of PLCδ::PH::GFP from PM. \*\*\*, P \< 0.001. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig8){#fig8}

Reducing hLgl levels increases cell survival under hypoxia {#s09}
----------------------------------------------------------

Loss of PM targeting under hypoxia likely inhibits the biological activity of Lgl, suggesting a possibility that reducing Lgl activity may in fact be beneficial for cells to survive hypoxia. We used an established hypoxia-induced cell death assay in HEK293 cells ([@bib13]) to investigate whether reducing Lgl activity by knocking down its protein levels promotes cell survival under hypoxia. We generated two stable HEK293 cell lines, hLgl-KD1 and hLgl-KD2, in which the endogenous human hLgl-1 protein levels were significantly reduced by the expression of shRNAs against *hLgl-1* ([Fig. 9 A](#fig9){ref-type="fig"}). We cultured these cell lines in 0.5% O~2~ hypoxic incubator for 3 d, and cell viability was determined daily by calcein AM and ethidium homodimer-1 staining. As shown in [Fig. 9 (B and C)](#fig9){ref-type="fig"}, compared with the control, shRNA line *hLgl-KD1* and *hLgl-KD2* showed significantly reduced cell death especially in the first day of hypoxic incubation, suggesting that reducing Lgl activity benefits cell survival under hypoxia.

![**Reducing hLgl levels increases cell survival under hypoxia.** (A) Protein levels of hLgl-1 are severely reduced in hLgl-KD1 and hLgl-KD2 stable lines expressing hLgl-1 shRNA, but not in the control cells that express scrambled shRNA. αTubulin (αTub) is the loading control. (B) Cell death in control, hLgl-KD1, and hLgl-KD2 cells incubated under normoxia or hypoxia (1% O~2~/5%CO~2~), respectively. Live cells are labeled by calcein AM (green), and dead cells are labeled by ethidium homodimer-1 (red). Cell death decreases after day 1 likely because old dead cells were lost by medium washes, which are required before dye staining. (C) Quantification of the cell viability after normoxia or hypoxia exposures in stable HEK293 cell lines expressing hLgl-1 shRNA (hLgl-KD1 and hLgl-KD2) or scrambled shRNA (Control) as shown in B. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. *ns*, not significant. Bars, 5 µm. Error bars represent means ± SEM.](JCB_201503067_Fig9){#fig9}

Discussion {#s10}
==========

In this report, we identified an evolutionarily conserved phosphorylatable PB domain that directly targets Lgl to the PM ([Fig. 10](#fig10){ref-type="fig"}). The PB domain in Lgl contains all the conserved phosphorylation sites of aPKC and Aurora kinases, providing a straightforward molecular mechanism by which phosphorylations on serine residues directly inhibit Lgl PM targeting by neutralizing the positive charges of Arg and Lys in the PB domain. Such a regulatory mechanism makes Lgl remarkably similar to another tumor suppressor, myristoylated alanine-rich C kinase substrate protein (MARCKS), whose PM targeting requires its PB effector domain, which is also a PKC substrate ([@bib2]; [@bib6]). In fact, adding the effector domain of MARCKS rescues the loss of PM targeting of mLgl^ΔPB^::GFP (Fig. S4 B). The lack of such PB domain in yeast Sro7 suggests that this is an evolutionarily acquired feature in metazoan Lgl, and our results highlight that phosphorylatable PB domain serves a conserved regulatory mechanism to control the PM targeting of Lgl and MARCKS. Based on our data, the cortical actin network is not required for Lgl PM targeting, and the strong PM targeting of nonphosphorylatable Lgl^S5A^ suggests that phosphorylation-dependent binding of Lgl to Dlg ([@bib46]) is unlikely essential for Lgl PM localization either. However, our results emphasize the critical roles of PM PIP2 in regulating cell polarity, as reported recently in *Drosophila* ([@bib14]).

![**Hypoxia and phosphorylations regulate the PB domain--mediated PM targeting of Lgl.**](JCB_201503067_Fig10){#fig10}

Hypoxia and reduction of intracellular ATP levels reduce the PM inositol phospholipid levels, therefore inhibiting PM targeting of proteins such as Lgl that require binding to PIPs. To our knowledge, Lgl is the first polarity protein identified for such a PB domain-based PM targeting mechanism. Nonetheless, many proteins localize to the PM through electrostatic binding to phospholipids ([@bib23]; [@bib44]; [@bib20]), and our data suggest that potential disruption of their PM localization under hypoxia may have profound consequences for cell survival and function. Cancer cells in solid tumors often need to overcome and proliferate in hypoxic environments caused by poor angiogenesis ([@bib29]), and inhibiting the electrostatic interaction--mediated PM targeting may act as a potential mechanism for cancer cells to repress the activities of tumor suppressors such as Lgl under hypoxia.

Materials and methods {#s11}
=====================

Fly stocks and genetics {#s12}
-----------------------

*Drosophila* stocks: *sqh-GFP::MoeAD* ("MoeAD::GFP," which is a fusion between Moesin actin--binding domain and GFP ubiquitously expressed under *sqh* promoter; provided by D. Kiehart, Duke University, Durham, NC), *y w sqh^AX^; sqh::GFP* (ubiquitously expressing Sqh::GFP fusion under *sqh* promoter in *sqh^AX^* background), *w par-6^Δ226^ FRT^9-2^/FM6* (provided by J. Knoblich, Institute of Molecular Pathology, Vienna, Austria), *y*; *sima^KG07607^/TM3, Sb Ser* (Bloomington Stock Center \[BL\] no. 14640), *fatiga(Hph)^02255^ry/TM3, Sb Ser* (BL no. 11561), *y w; aPKC^k06403^/CyO* (BL no. 10622), *w; His2Av::mRFP* (BL no. 23651), *y w Ubi-GFP^NLS^ FRT^9-2^* (BL no. 5154), *w; Act5C(FRT.CD2)-Gal4, UAS-RFP/TM3, Sb* (BL no. 30558), *w; UAS-Sima* (provided by P. Wappner, FCEyN-Universidad de Buenos Aires, Buenos Aires, Argentina), *UAS-PLCδ-PH::GFP* (BL no. 39693), *UAS-GRP1-PH::GFP(tGPH)* (BL no. 8163), *UAS-Numb::GFP* (provided by F. Roegiers, Fox Chase Cancer Center, Philadelphia, PA) and *UAS-aPKC-RNAi* (BL no. 25946). *w UASp\>mRFP::FKBP-5Ptase* and *w; UASp\>Lck-FRB::CFP* were provided by S. De Renzis (European Molecular Biology Laboratory, Heidelberg, Germany; [@bib38]). *Cy2-Gal4* (driving ubiquitous expression in follicular cells in late-stage ovaries; provided by G. Schupbach, Princeton University, Princeton, NJ). Generation of *lgl::GFP* knock-in alleles was described previously ([@bib24]). Generation of *lgl::mCherry, lgl^S5A^::GFP, lgl^ΔPB^::GFP*, and *lgl^KR12A^::GFP* knock-in alleles was performed according to a modified genomic engineering approach ([@bib25]). Each *lgl* knock-in allele contains an ∼7-kb genomic DNA of *lgl* that was modified in pGE-attB vector and inserted back into *lgl* locus through øC31-mediated DNA integration ([@bib24]). *Drosophila* cultures and genetic crosses were performed at 25°C. Clonal expression of Numb::GFP was achieved by heat-shocking *w hs-FLP/+; UAS-Numb::GFP/Act5C(FRT.CD2)-Gal4, UAS-RFP* females to activate *Act5C-Gal4*. Detailed information about the strains from Bloomington Stock Center can be found in FlyBase.

Live imaging of Lgl::GFP under hypoxia in *Drosophila* and mammalian cells {#s13}
--------------------------------------------------------------------------

Embryos were collected overnight at 25°C and dechorinated before imaging. Ovaries were dissected in halocarbon oil (no. 95) from adult females at the desired age. Embryos or ovaries were mounted in halocarbon oil on a gas-permeable slide that ensures efficient gas exchange between the mounted samples and the environment ([@bib26]). The slide was then mounted in an air-tight custom-made micro chamber that allows live imaging of samples under confocal microscope. Oxygen levels inside the chamber were controlled by air or custom O~2~/N~2~ flowing at ∼1--5 cc/s. Gas flow rates were constantly monitored throughout the imaging session. All custom hypoxic gas mixtures are balanced with N~2~. Imaging assays were performed at room temperature (25°C) on a confocal microscope (PL APO 40× oil objective; NA = 1.25; TCS-NT; Leica) with Leica software (TCS-NT), a confocal microscope (40× oil objective; NA = 1.3; LSM 510; Carl Zeiss) with Carl Zeiss software, or a confocal microscope (40× Uplan FL N oil objective; NA = 1.3; FV1000; Olympus) with Olympus software (FV10-ASW). HEK293 cells were cultured in glass-bottom dishes (In Vitro Scientific) with a gas-permeable membrane mounted above the cell. An air-tight custom-made micro chamber cap was used to seal the dish for the live confocal imaging assays under hypoxia. Polarized MDCK cells were cultured on 12-mm diameter Transwell filters (Corning). After cells reached confluence, the filter was cut and then mounted with a gas-permeable membrane in a special imaging micro chamber for live imaging under hypoxia at 37°C on a confocal microscope (40× oil objective; NA = 1.3; LSM 510; Carl Zeiss) with Carl Zeiss software or a confocal microscope (Plan Fluo 40× oil objective; NA = 1.3; A1; Nikon) with NIS-Elements AR software. All hypoxic gas mixtures for cultured cell live imaging were balanced with N~2~ plus 5% CO~2~. All confocal images were processed in Adobe Photoshop software.

Quantification of Lgl::GFP PM localization and subcellular redistribution {#s14}
-------------------------------------------------------------------------

PM localizations were measured in ImageJ (National Institutes of Health \[NIH\]). For each cell, mean intensities of PM, cytosol, and background (outside the cell) were traced and measured using line and area measurement tools in ImageJ. The PM localization was then calculated as the ratio of (PM − background)/(cytosol − background). To measure Lgl::GFP subcellular redistribution over the hypoxia treatment in Fig. S1 (B and C), we developed a custom ImageJ macro (see [supplemental material](http://www.jcb.org/cgi/content/full/jcb/DC1){#supplnk7ec31ad9-2357-7aae-7efd-c90d1dc1f78}) that quantifies the PM localization of Lgl::GFP as *PM localization index (PI)*, which is calculated as GFP~px0~/GFP~px2~, where *GFP~px0~* and *GFP~px2~* are the mean GFP intensities at the cell cortex and at two pixels away, respectively. The degree of Lgl::GFP cytosolic diffusion at 60 min of hypoxia treatment is quantified as *diffusion index (*DI*)* = *(PI~0min~^hypoxia^ − 1)/(PI~60min~^hypoxia^ − 1)*. Conversely, *recovery index* (RI) of Lgl::GFP at 10 min of post-hypoxia reoxygenation is quantified as *RI* = *(PI~10min~^normoxia^ − 1)/(PI~60min~^hypoxia^ − 1)*.

Hypoxia and drug treatment of embryos and dissected ovaries {#s15}
-----------------------------------------------------------

Drug treatments of embryos were performed as described previously ([@bib26]). In brief, embryos were collected overnight, dechorionated by bleach, and washed. Then embryos were placed into a 1:1 mixture of octane and Schneider's medium containing drugs. DMSO was used as control. Embryos were shaken at 400 rpm for 30 min and rinsed with octane briefly before imaging. Ovaries from three to five females were dissected in 1× PBS, transferred to a drop of 20 µl Schneider's medium containing 0.5% cyanide or 1 µM AM. After 30 min, ovaries were washed with Schneider's medium and imaged live in air-permeable conditions, as described previously ([@bib26]). In brief, embryos or ovaries were placed on an air-permeable membrane (YSI Membrane Model 5793; YSI Inc.) that is sealed by vacuum grease over a 10 × 10--mm cut-through window on a custom-made plastic slide. After placing on the coverslip, the open membrane ensures the sufficient air exchange to samples during the imaging session.

Generation of mutant clones in follicular epithelia {#s16}
---------------------------------------------------

Mutant follicular cell clones of *lgl^ΔPB^::GFP*, *lgl^KR12A^::GFP*, *aPKC^k06403^*, and *par-6^Δ226^* were generated by the routine FLP/FRT technique. Clones were induced by heat-shocking young females at 37°C for 1 h, and ovaries were dissected 3 d after heat shock.

Immunostaining and confocal imaging {#s17}
-----------------------------------

Immunostaining of embryos and adult ovaries were performed as described previously ([@bib24]). Primary antibodies: rabbit anti-GFP ([@bib24]), 1:1,500; chicken anti-GFP (Aves Lab), 1:1,000; rabbit anti-Lgl (d-300; Santa Cruz Biotechnology, Inc.), 1:200; guinea pig against N-terminal 80 aa of Baz ([@bib24]), 1:500; rabbit and rat anti-Par6 ([@bib24]), 1:500; rabbit and mouse anti-dPatj, 1:1,000 ([@bib45]); mouse anti-Dlg (4F3, DSHB), 1:50; rabbit anti-aPKC (Santa Cruz Biotechnology, Inc.), 1:1,000; mouse anti-hLgl-2 (H00003993-M06; Abnova), 1:500; and rabbit anti--E-cadherin (3195S; Cell Signaling Technology), 1:200. Secondary antibodies: Cy2-, Cy3-, or Cy5-conjugated goat anti--rabbit IgG, anti--chicken IgG, goat anti--rat IgG, goat anti--mouse IgG, and goat anti--guinea pig IgG (all at 1:400; Jackson ImmunoResearch Laboratories, Inc.). Images were collected on confocal microscopes (FV1000; Olympus; Center for Biological Imaging, University of Pittsburgh Medical School) and processed in Adobe Photoshop for compositions.

Quantifying intracellular ATP levels in hypoxia- and cyanide-treated embryos {#s18}
----------------------------------------------------------------------------

Dechorinated embryos were weighted before hypoxia or cyanide treatments and were snap-frozen immediately in liquid nitrogen at the end of the treatments. After adding 250 µl of 6% perchloric acid per 20--40 mg embryos, embryos were homogenized and incubated on the ice for 10 min. After 10 min of spin-down at 12,000 *g* at 4°C, supernatant was neutralized to pH 7 by adding 44 µl 2M K~2~CO~3~, incubated for 30 min on ice, and centrifuged at 12,000 *g* for 10 min at 4°C. Supernatant was filtered using a 0.45-µm spin filter by 12,000 *g* for 5 min at 4°C and stored at −80°C until HPLC injection. Concentrations of ATP, ADP, and AMP were measured by HPLC according to established methods ([@bib11]). HPLC separation of adenylate nucleotides was performed on 20 µl of extract using a gradient-mobile phase on a Waters XBridge Shield RP18 column and the following conditions: flow rate of 0.8 µl/min, detection wavelength of 257 nm, and column temperature of 30°C. The gradient consisted of 100% Buffer A from 0 to 6.5 min, 100% Buffer B from 6.5 to 12.5 min, and 100% Buffer A from 12.5 to 25 min. Buffer A was 50 mM NH~4~H~2~PO~4~, pH 5.7; Buffer B was 60:40 acetonitrile/H~2~O. Adenylate standards were linear through the range of 100--250 µM. Retention times were ∼4.2, 4.7, and 6.2 min for ATP, ADP, and AMP, respectively.

Liposome pull-down assays {#s19}
-------------------------

The GST and GST fusion proteins were purified from bacteria BL21. After a 1-h induction of 0.1 mM IPTG under 25°C, bacteria were harvested and sonicated on ice. The GST proteins were purified by glutathione agarose (Thermo Fisher Scientific). Liposomal binding assays were performed as described in [@bib31]. Liposomes were prepared via mixing lipids PC, PS, PE, cholesterol, and PIP~2~ or PI4P (all purchased from Avanti Polar Lipids, Inc.) at the proportions of 37.5, 10, 37.5, 10, and 5.0%. The mixture was dried and resuspended to a final concentration of 1 mg/ml of total phospholipids in Hepes buffer (50 mM Hepes, 100 mM NaCl, and 0.5 mM EDTA). After 30 min of sonication, liposomes were centrifuged at 16,000 *g* for 10 min and resuspended in binding buffer (20 mM Hepes, 120 mM KCl, 20 mM NaCl, 1 mM EGTA, 1 mM MgCl, and 1 mg/ml BSA). 50 µl of liposome suspension was mixed with 0.1 µg of purified protein and incubated at room temperature for 15 min. Liposomes were pelleted at 16,000 *g* for 10 min, and bound proteins were analyzed by Western blot.

Drug treatments in mammalian cells {#s20}
----------------------------------

Ionomycin and PAO treatments: HEK293 cells were seeded in a glass-bottom dish and cotransfected with R-pre::GFP (21179; Addgene) or PLCδ::GFP (17274; Addgene) and mLgl::RFP. 24 h after transfection, cells were treated with 10 µM ionomycin or 10 µM PAO. For 2-DG and AM treatments, HEK293 cells were seeded in a glass-bottom dish and cotransfected with GAP-43::GFP and mLgl::RFP. 24 h after transfection, the cells were serum and glucose starved for another 12 h, and then treated with 1 µM 2-DG and 10 mM AM. For cytochalasin D treatment, stable line MDCK-mLgl-GFP cells were treated with either 25 µg/ml cytochalasin D or 0.5% EtOH (solvent control) for 30 min. Cells were then fixed and stained with TRITC-phalloidin to label the F-actin. Images were taken by a confocal microscope (Plan Fluo 40 × oil objective; NA = 1.3; A1; Nikon) by NIS-Elements AR software under room temperature.

Generation of hLgl shRNA knockdown cell lines {#s21}
---------------------------------------------

hLgl1-specific shRNA with a 19-nucleotide targeting sequence (5′-GCGCGAAGACCAAGTTCAA-3′) was synthesized and cloned into pLKO1-TRC vector according to the instructions from Addgene. A scrambled control shRNA (5′-CCTAAGGTTAAGTCGCCCTCG-3′) in the same expression vector was purchased from Addgene. HEK293 cells were transfected using X-treme Gene 9 DNA transfection reagent (Roche). After 24 h, cultures were switched to complete medium containing 2 µg/ml puromycin. 1 wk after transfection, isolated cell clones were picked up and cultured in a 24-well plate to expand into clones. Cell lines were screened by Western blot using anti--hLgl-1 antibody (Cell Signaling Technology) at a 1:1,000 dilution. Details of molecular cloning of the plasmids used in this paper are available upon request.

Hypoxia-induced cell death assays in HEK293 cells {#s22}
-------------------------------------------------

HEK293-hLgl-KD1, HEK293-hLgl-KD2, and HEK293 control cells were cultured in DMEM supplemented with 10% FBS and 200 µg/ml G418. For the hypoxia experiments, cells were seeded in 6-well plates at 10^6^ cells/well and cultured under normoxic conditions for 1 d. After they reached ∼50--60% confluence, the medium was replaced by fresh DMEM plus 10% FBS, and plates were then placed into an incubator with 1% O~2~, 5% CO~2~, and 94% N~2~ for up to 4 d. Cell viability was determined after 1, 2, and 3 d using a live/dead viability/cytotoxicity kit (L-3224; Molecular Probes). In accordance with the manufacturer's protocol, cells were washed with PBS once before being subjected to calcein AM (3 µM) and ethidium homodimer-1 (4 µM) staining for 40 min under room temperature. Culture plates were examined under a confocal microscope (LSM 510; Carl Zeiss) using a 40× oil objective (NA = 1.3). For quantification, three individual experiments were performed with live and dead cells counted using ImageJ.

Induction of FKBP12-phosphatase and Lyn11-FRB::CFP dimerization in HEK293 cells {#s23}
-------------------------------------------------------------------------------

HEK293 cells cultured in 35-mm glass-bottom dishes (In Vitro Scientific) as described in the preceding section were transiently transfected with 1 µg of total DNA with 3 µg lipofectamine 2000 in Opti-MEM according to the manufacturer's instructions. cDNAs included the Lyn11-FRB::CFP recruiter, FKBP12-phosphatases ([@bib20]), iRFP::PLCδ-PH ([@bib27]), and iRFP::SidM-P4M ([@bib21]) as indicated. After 22--26 h, they were imaged in Fluoro-Brite medium (Life Technologies) using a confocal laser-scanning microscope (A1R; Nikon) though a 100×, NA/1.45 plan apochromatic objective lens. Time-lapse imaging began 2 min before bath addition of 1 µM rapamycin. PM localization was calculated from the ratio of fluorescence within the PM (defined by a binary mask derived from the CFP::Lyn11-FRB image) to the whole cell, and is expressed relative to the mean before rapamycin addition. The procedure has been described in detail previously ([@bib21]).

Ex vivo induction of mRFP::FKBP-5Ptase and Lck-FRB::CFP dimerization in *Drosophila* follicular cells {#s24}
-----------------------------------------------------------------------------------------------------

Young females of *w UASp\>mRFP::FKBP-5Ptase/+; lgl::GFP hs-FLP/+; Act5C(FRT.CD2)-Gal4 UAS-RFP/UASp\>Lck-FRB::CFP* were heat-shocked at 37°C for 1 h, and 4 d later, their ovaries were dissected in 1× PBS and transferred to a drop of 20 µl Schneider's medium containing either 0.01% DMSO or 10 µM rapamycin. Ovaries were then imaged live in air-permeable conditions, as described in the preceding section.

Genotypes of *Drosophila* samples in figures {#s25}
--------------------------------------------

[Fig. 1](#fig1){ref-type="fig"}: (A) *w; lgl::GFP.* (B) *w; lgl::GFP FRT^G13^ His2Av::mRFP.* (C) *w; sqh-GFP::MoeAD (MoeAD::GFP)* and *sqh^AX^; sqh::GFP.* (D) w; *lgl::GFP* and *w^1118^*. (E) *w; lgl::GFP.* [Fig. 2](#fig2){ref-type="fig"}: (A) *w; lgl::GFP/+; sima^KG07607^*; *w; lgl::GFP/+; fatiga^02255^* and *w; lgl::GFP/+; fatiga^1^ sima^KG07607^.* (B) *w par-6^Δ226^ FRT^9-2^/w ubi-GFP^NLS^ FRT^9-2^; lgl::GFP hs-FLP^38^/lgl::GFP* and *w hs-FLP/+; lgl::GFP FRT^G13^ aPKC^K06403^/lgl::GFP FRT^G13^ His2Av::mRFP;* (C) *w hs-FLP/+; lgl::GFP ubi-RFP^NLS^ FRT^40A^/lgl^S5A^::GFP FRT^40A^.* [Fig. 3](#fig3){ref-type="fig"}: (A and B) w; *lgl::GFP.* [Fig. 4](#fig4){ref-type="fig"}: (A) *w; lgl::mCherry sqh-GFP::MoeAD ("MoeAD::GFP").* [Fig. 6](#fig6){ref-type="fig"}: (A) *w hs-FLP/+; Lgl^ΔPB^::GFP FRT^40A^/ubi-RFP^NLS^ FRT^40A^; w hs-FLP/+; lgl^KR12A^::GFP FRT^40A^/ubi-RFP^NLS^ FRT^40A^ and w; lgl::GFP.* (B) *w hs-FLP/+; lgl::GFP ubi-RFP^NLS^ FRT^40A^/Lgl^KR12A^::GFP FRT^40A^*. (C) *w hs-FLP/+; Lgl^ΔPB^::GFP FRT^40A^/ubi-RFP^NLS^ FRT^40A^ and w hs-FLP/+; lgl^KR12A^::GFP FRT^40A^/ubi-RFP^NLS^ FRT^40A^.* [Fig. 7](#fig7){ref-type="fig"}: (B) *y w UASp-mRFP::FKbP-5Ptas/+; lgl::GFP hs-FLP/+; Act5C(FRT.CD2)-Gal4 UAS-RFP/UASp-Lck-FRB::CFP*. [Fig. 8](#fig8){ref-type="fig"}: (A) *Cy2-Gal4/UAS-PLCδ-PH::GFP; Cy2-Gal4/UAS-GRP1-PH::GFP* and *hs-FLP/+; UAS-Numb::GFP/Act5C(FRT.CD2)-Gal4, UAS-RFP.* Fig. S1: (A) *w; shg::GFP; w arm::GFP; w baz::GFP* and *w dlg::GFP.* Fig. S2: (A) *w; lgl::GFP hs-FLP^38^/lgl::GFP UAS-Sima; Act5C(FRT.CD2)-GAL4 UAS-RFP/+.* (B) *w par-6^Δ226^ FRT^9-2^/w Ubi-GFP^NLS^ FRT^9-2^; lgl::GFP hs-FLP^38^* and *w hs-FLP; lgl::GFP FRT^G13^ aPKC^K06403^/lgl::GFP FRT^G13^ His2Av::RFP.* (C) *w; lgl::GFP*. (D) *w; lgl::GFP hs-FLP^38^/lgl::GFP UAS-aPKC^CAAX^; Act5C(FRT.CD2)-GAL4, UAS-RFP/+.* Fig. S3: (A) *w^1118^*. (D) *w^1118^* and *w; lgl::GFP*. Fig. S4: (C) *w hs-FLP/+; lgl::GFP ubi-RFP^NLS^ FRT^40A^/lgl^ΔPB^::GFP FRT^40A^* and *w hs-FLP/+; lgl::GFP ubi-RFP^NLS^ FRT^40A^/lgl^KR12A^::GFP FRT^40A^*. (D) *w; Gal80 FRT^40A^/lgl^null^ FRT^40A^; UAS-aPKC-RNAi/hs-FLP Act5C(FRT.CD2)-Gal4 UAS-RFP* and *w; Gal80 FRT^40A^/lgl^KR12A^ FRT^40A^; UAS-aPKC-RNAi/hs-FLP Act5C(FRT.CD2)-Gal4 UAS-RFP.* Fig. S5: (A and B) *w; lgl::GFP.*

Online supplemental material {#s26}
----------------------------

Fig. S1 shows that hypoxia does not disrupt cell polarity in *Drosophila* embryonic cells. Fig. S2 shows that inhibition of Lgl PM targeting by hypoxia is modulated by Sima activity but is independent of aPKC/Par-6 complex. Fig. S3 shows that hypoxia reduces intracellular ATP levels to inhibit Lgl PM targeting in *Drosophila* embryonic epithelial cells and in human MCF-7 breast cancer cells. Fig. S4 shows that the PB domain is both essential for Lgl PM targeting and its functions in vivo. Fig. S5 shows that PM phospholipids are required for targeting Lgl. Video 1 shows the reversible inhibition of Lgl::GFP and His2Av::RFP in follicular cells under hypoxia. Video 2 shows PM relocalization of Lgl::GFP during post-hypoxia reoxygenation. Video 3 shows the loss of mLgl::GFP PM targeting in MDCK cells under hypoxia. Video 4 shows the recovery of PM targeting of mLgl::GFP in hypoxia-treated HEK293 cells. Video 5 shows the loss of mLgl::GFP PM targeting by rapamycin-induced PM recruitment of PJ::RFP in HEK293 cells. "ImageJ_Macro-1.txt" is the ImageJ macro used to measure cortical Lgl::GFP localization. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201503067/DC1>.

Supplementary Material
======================

###### Supplemental Material

We are grateful to Patty Chiu and Dr. Kenneth Hallows for technical assistance; Drs. Tamas Balla, Sergio Grinstein, Pablo Wappner, Jurgern Knoblich, Stefano De Renzis, Fabrice Roegiers, and Daniel Kiehart for reagents and fly stocks; Dr. Simon Watkins and University of Pittsburgh Medical School Center for Biological Imaging (supported by NIH grant 1S10OD019973-01) for generous imaging and microscopy support; Drs. Patrick Thibodaux and Marijn Ford for PyMOL visualization; Bloomington Stock Center for fly stocks; and Developmental Studies Hybridoma Bank for antibodies.

This work was supported by grants NIH-NCRR R21RR024869 (to Y. Hong), NIH-NIGMS R01GM086423 (to Y. Hong), R01GM103369 (to M.J. Palladino), and RSG-11-120-01-CCG (to Y. Hong) from the American Cancer Society.

The authors declare no competing financial interests.

Abbreviations used in this paper:2-DG2-deoxyglucoseAMantimycin AaPKCatypical PKCHIF1αhypoxia-inducible factor 1αLgllethal giant larvaeMDCKMadin-Darby canine kidneyPAOphenylarsine oxidePBpolybasicPHDprolyl hydroxylase domainPI4Pphosphatidylinositol 4-phosphatePIPphosphatidylinositol phosphatePIP2phosphatidylinositol 4,5-bisphosphatePJPseudojaninPMplasma membrane

[^1]: W. Dong and X. Zhang contributed equally to this paper.

[^2]: W. Liu's present address is Division of Biological Sciences, University of Missouri, Columbia, MO 65211.
